Bentovim Lyron L
Transaction: 12/18/2025
BUY
Change
+3,172
Price
$0.98
Filing
12/19/2025
Type
BUY
The Glimpse Group, Inc.
VRAR • Software - Application
Strong market move
VRAR+11.56%
vs. previous close $0.74
$0.83
▲ +0.09 (+11.56%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$17.49M
Growth
24.6%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 12.7%Manageable debt level · 0.01Healthy liquidity · 3.49Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.83
Change11.56%
Market Cap$17.49M
52W Range0.50 - 1.85
Beta1.21
Gross Margin67.63%
Oper. Margin-26.05%
Profit Margin-24.25%
Debt/Eq0.01
Current Ratio3.49
Quick Ratio3.49
Revenue 5Y24.61%
Price$0.83
Change11.56%
Market Cap$17.49M
52W Range0.50 - 1.85
Beta1.21
Gross Margin67.63%
Oper. Margin-26.05%
Profit Margin-24.25%
Debt/Eq0.01
Current Ratio3.49
Quick Ratio3.49
Revenue 5Y24.61%
Target$12.00
Target Upside1345.78%
Target Median$12.00
Target Range12.00 - 12.00
Volume498.98K
Avg Volume310.02K
EPS Surprise-0.59
Investment DNA
How strong this company looks for long-term investors
54
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
86/100
Why this score▼
Positive revenue growth · 12.7%Manageable debt level · 0.01Healthy liquidity · 3.49Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-06-19
Low
$12.00
Mean
$12.00
Median
$12.00
High
$12.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Bentovim Lyron L
Transaction: 12/11/2024
BUY
Change
+10,634
Price
$1.15
Filing
12/11/2024
Type
BUY
Bentovim Lyron L
Transaction: 04/03/2023
BUY
Change
+7,099
Price
$4.10
Filing
08/26/2024
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bentovim Lyron L | BUY | +3,172 | $0.98 | 12/18/2025 | 12/19/2025 |
| Bentovim Lyron L | BUY | +10,634 | $1.15 | 12/11/2024 | 12/11/2024 |
| Bentovim Lyron L | BUY | +7,099 | $4.10 | 04/03/2023 | 08/26/2024 |
| Elkeles Tamar | BUY | +20,000 | $2.50 | 04/29/2024 | 06/04/2024 |
| Bentovim Lyron L | BUY | +1,780 | $1.07 | 05/24/2024 | 05/28/2024 |
| Bentovim Lyron L | BUY | +1,214 | $1.07 | 05/23/2024 | 05/24/2024 |
| Bentovim Lyron L | BUY | +2,755 | $1.07 | 05/22/2024 | 05/23/2024 |
| Bentovim Lyron L | BUY | +1,900 | $1.03 | 05/21/2024 | 05/22/2024 |
| RUCKDAESCHEL ALEXANDER | BUY | +25,000 | Not reported | 03/01/2024 | 03/05/2024 |
| Gates Tyler | BUY | +5,532 | Not reported | 03/01/2024 | 03/05/2024 |
| Enslin Jeffrey D. | BUY | +25,000 | Not reported | 03/01/2024 | 03/05/2024 |
| Smith David John | BUY | +51,480 | Not reported | 03/01/2024 | 03/05/2024 |
| Rothblum Maydan | BUY | +306,145 | Not reported | 03/01/2024 | 03/05/2024 |
| Charles Ian Morgan | BUY | +24,000 | $2.50 | 03/01/2024 | 03/05/2024 |
| Bentovim Lyron L | BUY | +72,153 | Not reported | 03/01/2024 | 03/05/2024 |
| Amen Lemuel | BUY | +25,000 | Not reported | 03/01/2024 | 03/05/2024 |
| RUCKDAESCHEL ALEXANDER | SELL | -37,778 | Not reported | 02/29/2024 | 03/05/2024 |
| Gates Tyler | SELL | -9,216 | Not reported | 02/29/2024 | 03/05/2024 |
| Enslin Jeffrey D. | SELL | -359,385 | Not reported | 02/29/2024 | 03/05/2024 |
| Smith David John | SELL | -64,349 | Not reported | 02/29/2024 | 03/05/2024 |